WENDY FROST: Open Payments
NPI 1215053186 · GREAT NECK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 57 payments from 16 companies in 2025. Trend: 2023 $1,419 · 2024 $951 · 2025 $1,359
Food & beverage: $1,269Education: $90
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $307 |
| MILLICENT US INC | 7 | $223 |
| Evofem Biosciences, Inc. | 16 | $221 |
| Sumitomo Pharma America, Inc. | 5 | $101 |
| Astellas Pharma US Inc | 4 | $95 |
| Exeltis, USA Inc. | 4 | $81 |
| ABBVIE INC. | 2 | $63 |
| Travere Therapeutics, Inc. | 2 | $50 |
| CooperSurgical, Inc. | 2 | $43 |
| UCB, Inc. | 2 | $37 |
Products named: Phexxi, ANNOVERA, MYFEMBREE, Veozah, FEMLYV, SLYND, BOTOX, INTRAROSA.
Industry payments across NY — which companies pay providers there.
